Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Response: Optical Coherence Tomography Angiography of Optic Disc and Macula Vessel Density in Glaucoma and Healthy Eyes.

Yip VCH, Wong HT, Yong VKY, Lim BA, Hee OK, Cheng J, Fu H, Lim CW, Tay ELT, Loo-Valdez RG, Teo HY, Lim APH, Yip LWL.

J Glaucoma. 2019 Jul;28(7):e132-e133. doi: 10.1097/IJG.0000000000001289. No abstract available.

PMID:
31135585
2.

Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex.

Wong YH, Goh BC, Lim SY, Teo EW, Lim APC, Dedon PC, Hanson BJ, MacAry PA, Lescar J.

J Virol. 2017 Aug 10;91(17). pii: e00406-17. doi: 10.1128/JVI.00406-17. Print 2017 Sep 1.

3.

Effective removal of lead (II) ions by dead calcareous skeletons: sorption performance and influencing factors.

Lim AP, Zulkeflee Z, Aris AZ.

Water Sci Technol. 2016 Oct;74(7):1577-1584.

PMID:
27763337
4.

Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.

Lai J, Tan WJ, Too CT, Choo JA, Wong LH, Mustafa FB, Srinivasan N, Lim AP, Zhong Y, Gascoigne NR, Hanson BJ, Chan SH, Chen J, MacAry PA.

Blood. 2016 Sep 8;128(10):1396-407. doi: 10.1182/blood-2016-03-707836. Epub 2016 Jun 23.

5.

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.

Marachelian A, Desai A, Balis F, Katzenstein H, Qayed M, Armstrong M, Neville KA, Cohn SL, Bush M, Gunawan R, Lim AP, Smith MA, Smith LM.

Cancer Chemother Pharmacol. 2016 Feb;77(2):405-12. doi: 10.1007/s00280-015-2955-9. Epub 2016 Jan 20.

6.

Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma.

Desai AV, Fox E, Smith LM, Lim AP, Maris JM, Balis FM.

Cancer Chemother Pharmacol. 2014 Nov;74(5):1047-55. doi: 10.1007/s00280-014-2575-9. Epub 2014 Sep 12.

PMID:
25212536
7.

The role of phage display in therapeutic antibody discovery.

Chan CE, Lim AP, MacAry PA, Hanson BJ.

Int Immunol. 2014 Dec;26(12):649-57. doi: 10.1093/intimm/dxu082. Epub 2014 Aug 18. Review.

PMID:
25135889
8.

Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.

Chan KR, Ong EZ, Tan HC, Zhang SL, Zhang Q, Tang KF, Kaliaperumal N, Lim AP, Hibberd ML, Chan SH, Connolly JE, Krishnan MN, Lok SM, Hanson BJ, Lin CN, Ooi EE.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2722-7. doi: 10.1073/pnas.1317454111. Epub 2014 Jan 13.

9.

Dengue virus neutralization in cells expressing Fc gamma receptors.

Chawla T, Chan KR, Zhang SL, Tan HC, Lim AP, Hanson BJ, Ooi EE.

PLoS One. 2013 May 22;8(5):e65231. doi: 10.1371/journal.pone.0065231. Print 2013.

10.

Trace metal (Cd, Cu, Fe, Mn, Ni and Zn) accumulation in Scleractinian corals: a record for Sabah, Borneo.

Mokhtar MB, Praveena SM, Aris AZ, Yong OC, Lim AP.

Mar Pollut Bull. 2012 Nov;64(11):2556-63. doi: 10.1016/j.marpolbul.2012.07.030. Epub 2012 Aug 15.

PMID:
22901962
11.

The structural basis for serotype-specific neutralization of dengue virus by a human antibody.

Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, MacAry PA.

Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.

12.

A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.

Chan AH, Tan HC, Chow AY, Lim AP, Lok SM, Moreland NJ, Vasudevan SG, MacAry PA, Ooi EE, Hanson BJ.

PLoS One. 2012;7(4):e33451. doi: 10.1371/journal.pone.0033451. Epub 2012 Apr 3.

13.

Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.

Moreland NJ, Tay MY, Lim E, Rathore AP, Lim AP, Hanson BJ, Vasudevan SG.

J Virol Methods. 2012 Jan;179(1):97-103. doi: 10.1016/j.jviromet.2011.10.006. Epub 2011 Oct 20.

PMID:
22040846
14.

Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays.

Chan CE, Chan AH, Lim AP, Hanson BJ.

J Immunol Methods. 2011 Oct 28;373(1-2):79-88. doi: 10.1016/j.jim.2011.08.005. Epub 2011 Aug 12.

PMID:
21856306
15.

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Chan KR, Zhang SL, Tan HC, Chan YK, Chow A, Lim AP, Vasudevan SG, Hanson BJ, Ooi EE.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12479-84. doi: 10.1073/pnas.1106568108. Epub 2011 Jul 11.

16.

Optimized expression of full-length IgG1 antibody in a common E. coli strain.

Chan CE, Lim AP, Chan AH, MacAry PA, Hanson BJ.

PLoS One. 2010 Apr 20;5(4):e10261. doi: 10.1371/journal.pone.0010261.

17.

Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.

Prabhu N, Prabakaran M, Hongliang Q, He F, Ho HT, Qiang J, Goutama M, Lim AP, Hanson BJ, Kwang J.

Antivir Ther. 2009;14(7):911-21. doi: 10.3851/IMP1413.

PMID:
19918095
18.

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

Lim AP, Chan CE, Wong SK, Chan AH, Ooi EE, Hanson BJ.

Virol J. 2008 Oct 28;5:130. doi: 10.1186/1743-422X-5-130.

19.

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.

Lim AP, Wong SK, Chan AH, Chan CE, Ooi EE, Hanson BJ.

Virol J. 2008 Jul 11;5:80. doi: 10.1186/1743-422X-5-80.

20.
21.

Kinectin-kinesin binding domains and their effects on organelle motility.

Ong LL, Lim AP, Er CP, Kuznetsov SA, Yu H.

J Biol Chem. 2000 Oct 20;275(42):32854-60.

Supplemental Content

Support Center